High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosus.
Shinji MaedaHiroya HashimotoTomoyo MaedaShin-Ya TamechikaShuntaro IsogaiTaio NaniwaAkio NiimiPublished in: Lupus science & medicine (2023)
The study suggests an association between BEL treatment and variations in T cells, particularly Tregs, in SLE pathologies involving various immune cells.